LIPID PEROXIDE LEVELS IN TYPE-II HYPERLIPOPROTEINEMIC SUBJECTS

被引:0
|
作者
KAMEDATAKEMURA, K
CORDER, CN
LEE, DM
机构
[1] OKLAHOMA MED RES FDN,CLIN PHARMACOL PROGRAM,OKLAHOMA CITY,OK 73104
[2] UNIV OKLAHOMA HLTH SCI CTR,HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,OKLAHOMA CITY,OK 73104
关键词
OXIDATION; HYPERCHOLESTEROLEMIA; THIOBARBITURIC ACID; HEMOGLOBIN-METHYLENE BLUE; MALONDIALDEHYDE; LIPID PEROXIDES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to evaluate, under the most rigorous precautionary measures against in vitro oxidation, whether the baseline lipid peroxide levels in hypercholesterolemic subjects were higher than those in normolipidemic subjects. Two methods were employed: thiobarbituric acid (TBA), and hemoglobin-methylene blue (HbMB). Blood was collected into EDTA tube and centrifuged at 4-degrees-C for 30 min to collect plasma, then protected from in vitro oxidation with preservatives and N2. Serum was from blood samples allowed to clot at 20-degrees-C for 1 h, then protected from oxidation. Determination of lipid peroxide was carried out within 2 h of blood collection. Results from 35 hypercholesterolemic and 34 control subjects showed that lipid peroxide levels obtained from both methods were significantly higher in serum than in plasma for both groups, suggesting a greater rate of lipid peroxidation occurred in serum during clot formation. However, no significant difference in lipid peroxide levels was found between patients and controls in either serum or plasma by either assay method. No correlation existed between lipid peroxide values and plasma cholesterol or LDL-cholesterol levels. These results suggest that the mechanism for a higher tendency towards atherosclerosis in hypercholesterolemic subjects is not related to baseline levels of plasma lipid peroxide.
引用
收藏
页码:189 / 200
页数:12
相关论文
共 50 条
  • [1] Effect of gemfibrozil on levels of lipoprotein[a] in Type II hyperlipoproteinemic subjects
    Jones, PH
    Pownall, HJ
    Patsch, W
    Herd, JA
    Farmer, JA
    PaytonRoss, C
    Kimball, KT
    Gotto, AM
    Morrisett, JD
    JOURNAL OF LIPID RESEARCH, 1996, 37 (06) : 1298 - 1308
  • [2] HYPERCHOLESTEROLEMIC (TYPE-II HYPERLIPOPROTEINEMIC) ARTHRITIS
    RIMON, D
    COHEN, L
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (05) : 703 - 705
  • [3] ADRENOCORTICAL FUNCTION IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS TREATED WITH LOVASTATIN (MEVINOLIN)
    FOJO, SS
    HOEGG, JM
    LACKNER, KJ
    ANCHORS, JM
    BAILEY, KR
    BREWER, HB
    HORMONE AND METABOLIC RESEARCH, 1987, 19 (12) : 648 - 652
  • [4] INCREASED LYSOLECITHIN ACYLTRANSFERASE ACTIVITY IN THE PLASMA OF TYPE-II HYPERLIPOPROTEINEMIC PATIENTS
    SUBBAIAH, PV
    OGILVIE, JT
    LIPIDS, 1984, 19 (02) : 80 - 84
  • [5] TESTICULAR FUNCTION IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS TREATED WITH LOVASTATIN (MEVINOLIN) OR NEOMYCIN
    FARNSWORTH, WH
    HOEG, JM
    MAHER, M
    BRITTAIN, EH
    SHERINS, RJ
    BREWER, HB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03): : 546 - 550
  • [6] FETOMATERNAL LIPID-LEVELS IN A CASE OF TYPE-V HYPERLIPOPROTEINEMIC MOTHER
    RODRIGUEZALARCON, J
    RODRIGUEZESCUDERO, FJ
    SANJURJO, P
    MARTUL, P
    LINARES, A
    ANALES ESPANOLES DE PEDIATRIA, 1980, 13 (09): : 793 - 798
  • [7] EFFECTS OF BEZAFIBRATE ON RECEPTOR-MEDIATED AND RECEPTOR-INDEPENDENT LOW-DENSITY LIPOPROTEIN CATABOLISM IN TYPE-II HYPERLIPOPROTEINEMIC SUBJECTS
    STEWART, JM
    PACKARD, CJ
    LORIMER, AR
    BOAG, DE
    SHEPHERD, J
    ATHEROSCLEROSIS, 1982, 44 (03) : 355 - 365
  • [8] CHANGES IN LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES INDUCED BY ACIPIMOX IN TYPE-IV AND TYPE-II HYPERLIPOPROTEINEMIC PATIENTS
    SOMMARIVA, D
    POGLIAGHI, I
    BONFIGLIOLI, D
    CABRINI, E
    TIRRITO, M
    LAVEZZARI, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 37 (02): : 363 - 368
  • [9] INCREASED PLATELET SENSITIVITY AND THROMBOXANE-B2 FORMATION IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS
    TREMOLI, E
    MADERNA, P
    COLLI, S
    MORAZZONI, G
    SIRTORI, M
    SIRTORI, CR
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (05) : 329 - 333
  • [10] LIPID-METABOLISM IN TYPE-II DIABETES
    BOHANNON, NJV
    POSTGRADUATE MEDICINE, 1992, 92 (02) : 105 - &